89bio Appoints Healthcare Industry Veteran Steven Altschuler, M.D., as Chairman of the Board of Directors
March 25, 2020 16:05 ET
|
89bio, Inc.
SAN FRANCISCO, March 25, 2020 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for...
89bio Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
March 18, 2020 16:05 ET
|
89bio, Inc.
- BIO89-100 Phase 1b/2a NASH study on track for topline data in 2H20 - - Initiation of Phase 2 SHTG study planned in 1H20 - SAN FRANCISCO, March 18, 2020 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq:...
89bio to Present at the SVB Leerink 9th Annual Global Healthcare Conference
February 21, 2020 16:05 ET
|
89bio, Inc.
SAN FRANCISCO, Feb. 21, 2020 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for...
Novel Probiotic-Prebiotic supplement blend supports a healthy liver
January 23, 2020 10:00 ET
|
Life Extension
Fort Lauderdale, Fla., Jan. 23, 2020 (GLOBE NEWSWIRE) -- Because liver health is vital at any age, Life Extension® has developed a novel approach to supporting a healthy liver. FLORASSIST® Liver...
PROVECTUS BIOPHARMACEUTICALS ANNOUNCES CHANGES TO BOARD OF DIRECTORS
April 24, 2018 07:00 ET
|
Provectus Biopharmaceuticals Inc.
FOR IMMEDIATE RELEASE Ed Pershing, CPA elected new Board chair Jack Lacey, MD named new Board director; also appointed new strategic advisory board chair KNOXVILLE, TN, April 24, 2018 ...
SECOND STUDY OF EXPANDED ACCESS PATIENTS TREATED WITH PV-10 FOR IN-TRANSIT MELANOMA PUBLISHED IN JOURNAL OF SURGICAL ONCOLOGY
April 19, 2018 06:00 ET
|
Provectus Biopharmaceuticals Inc.
FOR IMMEDIATE RELEASE KNOXVILLE, TN, April 19, 2018 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, www.provectusbio.com) (“Provectus” or the “Company”), a...
Streetwise Reports Examines How One Analyst Says This Biotech Company Could Potentially 'Double'
November 15, 2017 09:00 ET
|
Streetwise Reports Llc
SAN FRANCISCO, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Analyst Grant Zeng of Zacks Small Cap Research examines what transpired with this biopharmaceutical company during Q3/17. Included in this article...
Biopsy Devices Market size to exceed $3bn by 2024: Global Market Insights Inc.
August 29, 2016 10:00 ET
|
Global Market Insights
Ocean View, Delaware, Aug. 29, 2016 (GLOBE NEWSWIRE) -- Biopsy Devices Market size is estimated to see USD 3.1 billion revenues by 2024; as reported by Global Market Insights, Inc. Growing...
Cempra to Present Anti-NASH Data for Solithromycin at The Liver Meeting(R) 2015
November 11, 2015 07:30 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Nov. 11, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
HEPREGEN ANNOUNCES PUBLICATION OF SEVERAL SCIENTIFIC PAPERS PROVIDING EVIDENCE OF THE UNPRECEDENTED UTILITY OF ITS HEPATOPACTM PRODUCTS
February 12, 2014 12:26 ET
|
Hepregen
MEDFORD, Mass., Feb. 12, 2014 (GLOBE NEWSWIRE) -- Hepregen Corporation, leader in the development of next generation HepatoPacTM and HepatoMuneTM cell-based in vitro assay products, announced today...